Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

Abstract Background The efficacy and safety of lapatinib plus capecitabine (LC or LX) versus trastuzumab plus chemotherapy in patients with HER-positive metastatic breast cancer who are resistant to trastuzumab is unknown. Methods We retrospectively analyzed data from breast cancer patients who bega...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Fan Yang, Xiang Huang, Chunxiao Sun, Jianbin Li, Biyun Wang, Min Yan, Feng Jin, Haibo Wang, Jin Zhang, Peifen Fu, Tianyu Zeng, Jian Wang, Wei Li, Yongfei Li, Mengzhu Yang, Jun Li, Hao Wu, Ziyi Fu, Yongmei Yin, Zefei Jiang
格式: Artigo
語言:Inglês
出版: BMC 2020-03-01
叢編:BMC Cancer
主題:
Lapatinib
Trastuzumab
Resistance
Breast cancer
在線閱讀:http://link.springer.com/article/10.1186/s12885-020-6639-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍